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The cyclic repetition of sleep and wakefulness states is essential to the basic functioning
of all higher animals, including humans. As understanding of the neurobiology of sleep
increases, clinicians no longer view it as a passive state (ie, sleep as merely the absence
of wakefulness). Sleep is an active neurobehavioral state that is maintained through a
highly organized interaction of neurons and neural circuits in the central nervous system
(CNS).

DEFINING SLEEP
Sleep physicians define human sleep on the basis of an individual's observed behavior
and accompanying physiologic changes in the brain's electrical activity as the brain
transitions between wakefulness and sleep. Behaviorally, human sleep is characterized by
reclined position, closed eyes, decreased movement, and decreased responsivity to
internal and external environment. The responsiveness to stimuli is not completely
absent; a sleeper continues to process some sensory information during sleep, and
meaningful stimuli are more likely to produce arousals than nonmeaningful ones. A
sound of one's own name is more likely to arouse a sleeper than some other sound, and
the cry of her infant is more likely to arouse a sleeping mother than a cry of another
infant.
CONSTITUENTS OF SLEEP
Sleep consists of two strikingly different states, rapid-eye-movement (REM) sleep and
non-REM (NREM) sleep. NREM sleep can be subdivided further into four stages.
Polysomnography is the “gold standard” technique that simultaneously records the three
physiologic measures that define the main stages of sleep and wakefulness. These
measures include muscle tone, recorded through electromyogram (EMG); eye
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movements, recorded through electro-oculogram (EOG); and brain activity, recorded
through electroencephalogram (EEG) [1]. The clinical polysomnogram, the purpose of
which is to detect findings that are characteristic of certain sleep disorders, includes, in
addition to these three variables, the following: monitors for airflow at the nose and
mouth, respiratory effort strain gauges placed around the chest and abdomen, and
noninvasive oxygen saturation monitors that function by introducing a beam of light
through the skin. Other parameters include the electrocardiogram and EMG of the
anterior tibialis muscles, which are intended to detect periodic leg movements. Finally, a
patient's gross body movements are monitored continuously by audiovisual means.
The EEG pattern of drowsy wakefulness consists of low-voltage rhythmic alpha activity
(8–13 cycles per second [Hz]). In stage 1 of NREM sleep, the low-voltage mixed
frequency theta waves (4–8 Hz) replace alpha rhythm of wakefulness. Slow
asynchronous eye movements are seen on the EOG in the beginning of stage 1 sleep and
disappear in a few minutes. The muscle activity is highest during wakefulness and
diminishes as sleep approaches. Individuals with behavioral characteristics of sleep and
polysomnographic characteristics of stage 1 sleep may or may not perceive themselves as
sleeping. Stage 1 is viewed as a “shallow” sleep, during which an individual can be easily
aroused. With transition to stage 2, EEG patterns termed sleep spindles and K complexes
appear on the EEG. Sleep spindles are 12- to 14-Hz synchronized EEG waveforms with
duration of 1.5 seconds. Sleep spindle waves arise as a result of synchronization of
groups of thalamic neurons by the GABAergic thalamic spindle pacemaker. The origin of
K complexes is unknown. With the onset of stage 2, the arousal threshold increases, and a
more intense stimulus is needed to arouse a sleeper. Stages 3 and 4 of NREM sleep are
defined by synchronized high-amplitude (>75 µV) and slow (0.5–2 Hz) delta wave EEG
pattern. Stages 3 and 4 collectively are referred as deep sleep, delta sleep, or slow-wave
sleep. By definition, delta waves account for 20% to 50% of EEG activity during stage 3
and greater than 50% of EEG activity during stage 4 of sleep. Slow-wave sleep is
associated with a higher arousal threshold than “lighter” stages of NREM sleep. No eye
movements are detected on the EOG during stages 2, 3, and 4 of NREM sleep. The EMG
tracks continued muscle tone decline as NREM sleep “deepens” from stages 1 to 4.
The cortical EEG pattern of REM sleep is characterized by low voltage and fast
frequencies (alpha or 8–13 Hz). This EEG pattern is referred as activated or
desynchronized and also is seen in the state of relaxed wakefulness (with eyes closed).
Activated refers to an active mind (dreams) and the EEG pattern characteristic of
wakefulness. Paradoxically, individuals in REM sleep, although activated, are
behaviorally less responsive than during the wake state [2], [3]. Desynchronized refers to
the random-appearing wave pattern seen on the REM sleep EEG, which is contrasted
with the synchronized uniform wave pattern seen on the NREM sleep EEG [2], [3]. To be
scored as REM sleep, a polysomnographic tracing must contain an activated EEG pattern
and muscle atonia (EMG) and the presence of rapid eye movements (EOG). REM sleep
can be subdivided further into two stages: tonic and phasic. The tonic stage is continuous
and shows muscle atonia and desynchronized EEG as two main features. Superimposed
on the tonic stage of REM are intermittent phasic events, which include bursts of rapid
eye movements and irregularities of respiration and heart rate.

SLEEP ARCHITECTURE
Sleep typically begins with a “shallow” stage 1 of NREM sleep and “deepens” to NREM
sleep stages 2, 3, and 4, which are followed by the first brief episode of REM sleep in
approximately 90 minutes. After the first sleep cycle, NREM and REM sleep continue to
alternate in a predictable fashion, each NREM-REM cycle lasting approximately 90 to
120 minutes [1]. In the course of the night, sleep cycles recur three to seven times. Stage
1 of NREM sleep, which lasts only a few minutes, serves as a transition from
wakefulness to sleep and later during sleep serves as a transition between REM-NREM
sleep cycles. Typically, stage 1 constitutes 2% to 5% of total sleep time. An increase in
the amount or percentage of stage 1 sleep may be a sign of sleep disruption. The brief
first period of stage 1 NREM sleep is followed by “deeper” stage 2, which lasts
approximately 10 to 20 minutes. Stage 2 sleep normally constitutes 45% to 55% of the
total sleep time. Stage 2 sleep progresses to stages 3 (lasting a few minutes) and 4 (lasting
40 minutes). Stage 3 constitutes 5% to 8% of the total sleep time, and stage 4 constitutes
10% to 15% of the total sleep time. Stages 3 and 4 of NREM sleep predominate during
the first third of the night. The first REM period is brief and occurs approximately 90
minutes after sleep onset; subsequent REM cycles occur approximately 90 to 120 minutes
apart. REM sleep episodes become longer as the night progresses, and the longest REM
periods are found in the last third of the night [4], [5]. NREM sleep accounts for 75% to
80% and REM sleep accounts for 20% to 25% of the total sleep time [1], [3], [6], [7], [8]. These
proportions commonly vary with age (see later section on effects of age).
PHYSIOLOGIC FUNCTIONS IN SLEEP
AUTONOMIC NERVOUS SYSTEM DURING SLEEP
The parasympathetic drive is higher during all stages of sleep than in relaxed
wakefulness. The sympathetic drive increases significantly during phasic REM, decreases
slightly during tonic REM, and remains relatively unchanged during relaxed wakefulness
and NREM sleep. The net effect is the dominance of the parasympathetic tone during
NREM and tonic REM sleep, and the sympathetic dominance during phasic REM [9], [10],
[11]
.
BODY TEMPERATURE REGULATION
The energy expenditure is lower during NREM sleep compared with wakefulness. The
body temperature is maintained at a lower set-point in NREM than in wakefulness.
During REM sleep, thermoregulatory responses of shivering and sweating are absent, and
thermal regulation seems to cease (as in poikilothermic organisms) [9], [10], [11].
CONTROL OF RESPIRATION AND CARDIOVASCULAR FUNCTION DURING
SLEEP
The predominance of the parasympathetic tone and decreased energy expenditure during
NREM sleep are responsible for decreased ventilation during this stage. The respiration

rate in NREM sleep is regular, and cardiovascular changes are consistent with decreased
energy expenditure. In contrast, breathing patterns and heart rate during REM sleep are
irregular [9], [10], [11]. The irregularities in cardiovascular parameters increase the risk of
myocardial infarctions during REM sleep in vulnerable individuals. The changes in
ventilation, respiration, and upper airway tone make REM sleep a vulnerable period for
individuals with obstructive sleep apnea (Table 1).
EFFECTS OF AGE
Age is likely the strongest factor that affects sleep continuity and the distribution of sleep
stages through the night. The sleep pattern of newborn infants dramatically differs from
that of adults. During the first year of life, infants sleep twice as much as adults and, in
contrast to adults, enter sleep through REM. During the first year of life, REM sleep
constitutes 50% of the total sleep time; the percentage occupied by REM sleep decreases
to adult levels of 20% to 25% by age 3 years and remains at that level until old age.
NREM-REM cycles, controlled by the ultradian process, are present at birth, but the 50to 60-minute cycle periods in newborns are shorter than the approximately 90-minute
periods in adults. Slow-wave sleep is not present at birth, but develops by age 2 to 6
months. The amount of slow-wave sleep steadily declines from maximal levels in the
young to almost nonexistent amounts in the elderly [1], [10], [12]. In addition to loss of slowwave sleep, sleep changes in the elderly include sleep fragmentation, increased
percentage of stage 1 sleep, and decreased ability to maintain continuous sleep at night
and wakefulness during the day. Contrary to commonly held beliefs, the need to sleep
does not decrease with the advancing age; what changes in the elderly is the ability to
maintain sleep (Fig. 1) [10], [12], [13].
HOW MUCH SLEEP DOES ONE NEED?
One needs a sufficient amount of sleep to feel alert and refreshed and to avoid falling
asleep unintentionally during the waking hours. Most young adults average 7 to 8 hours
of sleep nightly, but there is a significant individual and night-to-night variability in these
figures. Genetics plays a role in determining sleep length, and voluntary sleep reduction
plays a significant role in determining how much sleep an individual actually gets. Sleep
restriction results in daytime sleepiness, and daytime sleepiness suggests that an
individual's sleep needs have not been met [1].

REGULATION OF SLEEP AND WAKEFULNESS
DRIVES
Experimental studies in humans and animals led to the development of the two-process
model, which accounts for regulation of sleep and wake time. According to the model,
sleep is regulated by two basic processes: a homeostatic process, which depends on the
amount of prior sleep and wakefulness, and a circadian process, which is driven by an
endogenous circadian pacemaker, generating nearly 24-hour cycles of behavior. An

ultradian process within sleep is believed to control the alternation between REMNREM sleep every 90 to 120 minutes. It is hypothesized that the interaction of
homeostatic and circadian processes is responsible for helping humans to maintain
wakefulness during the day and consolidated sleep at night (Fig. 2).
HOMEOSTATIC REGULATION OF SLEEP
Virtually all organisms have an absolute need to sleep. Humans cannot remain awake
voluntarily for longer than 2 to 3 days, and rodents cannot survive without sleep for
longer than few weeks [10], [14]. The homeostatic factor represents an increase in the need
for sleep (sleep pressure) with increasing duration of prior wakefulness. The presence of
homeostatic factor is best shown through sleep deprivation studies. When a normal
amount of sleep is reduced, the homeostatic drive is increased, leading to increased sleep
pressure and sleepiness during the day and increased deep sleep at night. When normal
sleep is preserved, the homeostatic factor represents a basic increase in sleep propensity
during waking hours. The pull of this drive builds up during wakefulness and reaches its
peak at sleep time. Its strength declines during sleep with the lowest point (nadir) on
awakening in the morning.
It also is useful to differentiate sleepiness from tiredness or fatigue. A tired or fatigued
individual does not have a propensity to fall asleep given an opportunity to do so. A
sleepy individual is not only anergic, but also falls asleep given the opportunity to do so.
CIRCADIAN RHYTHMS
Humans have an endogenous circadian pacemaker with an intrinsic period of slightly
more than 24 hours [15]. Virtually all living organisms exhibit metabolic, physiologic, and
behavioral circadian (ie, about 24 hours) rhythms. The most obvious circadian rhythm is
the human sleep-wake cycle. Examples of other circadian rhythms include the release of
cortisol, thyroid-stimulating hormone, and melatonin. Most mammalian tissues and
organs contain mechanisms capable of expressing their function in accordance with the
circadian rhythm. The “master biologic clock,” which regulates sleep-wake and all other
circadian rhythms, resides in the suprachiasmatic nuclei (SCN) of the hypothalamus.
SCN are bilaterally paired nuclei located slightly above the optic chiasm in the anterior
hypothalamus.
Circadian clocks normally are synchronized to environmental cues (zeitgebers) by a
process called entrainment. The process of entrainment of SCN cells is mediated through
glutamate stimulating the N-methyl-D-aspartate receptor [16]. Light hitting the retina
activates the release of glutamate through the retinohypothalamic tract projecting to the
SCN [17]. In most mammals and humans, light-dark cycle is the most potent entraining
stimulus. The modulation of the SCN by environmental cues and
neurotransmitters/hormones is phase dependent. When light is given to a patient at night,
it shifts the circadian clock back, whereas light exposure in early morning shifts the clock
forward; melatonin is effective only in shifting the circadian clock when given at dawn or

at dusk, but not during the daytime hours; cholinergic activation of the muscarinic
receptors affects the clock only at night [18], [19].
Circadian information from the SCN is transmitted to the rest of the body after input from
the hypothalamus. Body organ responses (eg, sleep-wake cycle, core body temperature,
the release of cortisol, thyroid-stimulating hormone, melatonin) to the circadian rhythm is
controlled by the SCN and modulated by the hypothalamus. The release of melatonin
from the pineal gland, signaled by the circadian rhythm, peaks at dawn and dusk. The
SCN contains melatonin receptors, and the circadian clock can be reset by melatonin
through a feedback mechanism [15], [18], [20]. In the absence of environmental cues (eg,
under conditions of sensory deprivation), the endogenous rhythmicity of the circadian
pacemaker persists independently of the light-dark cycle [18], [21]. The genes of the SCN
cells, through transcription-translation, are responsible for maintaining the 24-hour clock.
Experimental mutation of these genes in animals produces prolonged or shortened
circadian periods, whereas in humans such mutations result in abnormal circadian
rhythms [18].
NEUROTRANSMITTERS INVOLVED IN SLEEP AND WAKEFULNESS
Adenosine had been identified as a possible mediator of the homeostatic sleep process. It
is an endogenous sleep-producing substance [10], [18], [22], [23], [24]. A breakdown product of
adenosine triphosphate (ATP), adenosine is believed to be a homeostatic sleep factor that
mediates the transition from prolonged wakefulness to NREM sleep. Adenosine mediates
this transition by inhibiting arousal-promoting neurons of the basal forebrain. Caffeine is
believed to promote wakefulness by blocking adenosine receptors. ATP is an important
energy reserve in neurons. Adenosine accumulates in certain areas of the brain when
neurons consume energy in the form of ATP during prolonged wakefulness. In animal
studies, adenosine levels in the brain increased during sleep deprivation and returned to
baseline during sleep [14], [25], [26]. Other substances hypothesized to be involved in
promoting sleep and contributing to the homeostatic factor include proinflammatory
cytokines (interleukin-1) [18], [27] prostaglandin D2, and growth hormone–releasing
hormone [27].
Cholinergic neurons have a dual role: Some promote sleep, and others promote
wakefulness. The serotoninergic, noradrenergic, and histaminergic wakefulnesspromoting neurons have a discharge pattern nearly opposite that of the cholinergic sleeppromoting neurons. The discharge rate of serotoninergic, noradrenergic, and
histaminergic neurons is fastest during wakefulness, decreases during NREM sleep, and
virtually stops firing during REM sleep. Additionally, newly discovered peptides called
hypocretins (also known as orexins) are thought to regulate wakefulness by interacting
with histaminergic, aminergic, and cholinergic systems (Fig. 3).
ACETYLCHOLINE
Cholinergic neurons that originate in the laterodorsal and pedunculopontine tegmental
nuclei (LDT/PPT) of the midbrain reticular formation reach the cortex by ascending

through the thalamus and hypothalamus. These midbrain LDT and PPT areas contain two
interspersed subsets of cholinergic neurons. One subset is responsible for the fastfrequency and low-voltage EEG pattern of “cortical activation,” which appears in REM
sleep and restful wakefulness. These are called wake/REM-on neurons [28]. The second
subset is responsible for generations of REM sleep. These latter cholinergic neurons are
called REM-on cells. The three physiologic components of REM sleep (muscle atonia,
rapid eye movements, EEG activation/desynchronization) are controlled by different
nulei located in the pontine reticular formation (PRF). The REM-on cholinergic neurons
promote REM sleep by sending excitatory input to the PRF. This causes the rapid firing
of the PRF, which produces the three cardinal physiologic components of REM sleep.
The PRF is shut off during NREM sleep.
Cholinergic neurons that project from the basal forebrain to the cerebral cortex and
limbic areas are part of the vigilance-waking system. The side effects produced by
anticholinergic medications likely result owing to a disruption of the vigilance-wake
producing cholinergic neurons and the wake/REM-on cholinergic neurons.
SEROTONIN AND NOREPINEPHRINE
Serotoninergic neurons originate in the dorsal raphe nucleus and noradrenergic neurons
originate in the locus caeruleus. Both sets of neurons act as suppressants of REM sleep
(REM off cells) by inhibiting REM-promoting cholinergic neurons and by sending
inhibitory input to the PRF. Serotonin and norepinephrine neurons promote cortical
activation during wakefulness by rapid firing [29]. The noradrenergic wake-promoting
system also was found to have an important role in the cognitive function of learning
during the waking state. Activity of the noradrenergic system triggers an increase in the
expression of genes associated with memory formation and learning [18]. The
serotoninergic system was not found to have this close link to cognitive function.
During the NREM sleep period, at the beginning of the first sleep cycle, the
serotoninergic and noradrenergic neurons significantly reduce their firing rate. This
removes the inhibition from the REM-on cholinergic neurons; leading to the first REM
sleep period approximately 90 minutes later.
HYPOCRETIN
Hypocretins (also called orexins) are two neuropeptides (hypocretin 1 and hypocretin 2)
with key roles in regulation of arousal and metabolism. They bind to their corresponding
receptors (Hcrtr1 and Hcrtr2) throughout the brain and spinal cord. These peptides are
produced by hypothalamic neurons that surround the fornix bilaterally and in the
dorsolateral hypothalamus. These hypothalamic regions are implicated in control of
nutritional balance, blood pressure, and temperature regulation and endocrine secretion
and arousal. Hypocretins likely play a role in all of these functions [30].
The hypocretin-producing neurons in the hypothalamus receive direct input from the
SCN (the circadian rhythm clock) and project to the posterior hypothalamus

(tuberomammillary nucleus [TMN]–histamine), basal forebrain (cholinergic vigilancewake area), thalamus, locus caeruleus and dorsal raphe neucleus (norepinephrine and
serotonin REM off cells), LDT, and PRF (cholinergic REM-on cells and muscle atonia)
[30], [31]
. In accordance with circadian rhythm control of hypocretin levels (through SCN
input), their concentration is highest during the waking period. Hypocretin levels also
increase during a period of forced sleep deprivation. It is unclear whether this increase
during sleep deprivation represents hypocretin opposing and attempting to override the
sleep drive or producing a stress response to sleep deprivation. Hypocretin input to the
brainstem REM-on cells controls the switch into REM by reducing the firing rate of the
REM-on cells during the wake period [30].
HISTAMINE
Antihistaminergic drugs that cross the blood-brain barrier are known to produce sedation.
The neurotransmitter histamine plays a key role in maintenance of wakefulness.
Histaminergic neurons originate from the TMN of the posterior hypothalamus and project
diffusely throughout the brain. In the cortex, histamine facilitates cortical arousal.
Histaminergic neurons fire most rapidly during cortical activation in the wake state and
turn off during REM sleep [29], [32].
HYPOTHALAMUS
The role of the hypothalamus as a key area of the brain involved in regulation of sleep
and wakefulness was recognized after the pandemic of encephalitis lethargica swept the
world in the early 1900s. Thought to be a viral infection of the brain, encephalitis
lethargica induced severe sleep abnormalities in affected individuals. Most patients
exhibited profound and prolonged sleepiness, whereas some had severe insomnia.
Patients affected by sleepiness were discovered to have lesions in the posterior
hypothalamus; patients affected by insomnia were found to have lesions in the anterior
hypothalamus[23], [33].
Since this clinical observation more than 70 years ago, numerous human and animal
studies have elucidated further the role of the hypothalamus in the regulation of sleep. In
accordance with these original observations, the ventrolateral preoptic nucleus in the
anterior hypothalamus has been established as the key sleep-inducing region and the
TMN of the posterior hypothalamus as one of the important wakefulness-promoting
regions of the brain.
The anterior hypothalamus contains GABAergic cells. Activity of GABAergic cells in
the ventrolateral preoptic nucleus region is implicated in production of NREM sleep,
whereas the GABAergic cells in the area adjacent to the ventrolateral preoptic nucleus is
thought to promote REM sleep by inhibiting the noradrenergic (locus caeruleus) and
serotoninergic (dorsal raphe nucleus) REM-off nuclei of the brainstem [23]. The rapid
firing of the anterior hypothalamus region during sleep leads to inhibition of the locus
caeruleus and dorsal raphe nucleus in the brainstem. This in effect takes the

“noradrenergic and serotoninergic breaks” off the hypothalamic sleep generator,
reinforcing the sleep state [33].
The posterior hypothalamus/TMN receives histaminergic input and has hypocretin
receptors (hctr2). Histamine and hypocretin produce activation of the TMN cells, which
leads to sustained wakefulness [23]. At the same time, hypocretin activates the
noradrenergic and seretoninergic cells in the brainstem, which send inhibitory signals to
the anterior hypothalamus. This in effect takes the “GABAergic breaks” off the
hypothalamic wakefulness generator, reinforcing the wake state.
From the point of view of evolutionary advantage, it may be important for most animals
to be either in the fully awake or the fully asleep state and to spend little time in the
transition state between sleep and wakefulness. The anterior and posterior regions of the
hypothalamus work through a system of mutual inhibition in what has been referred to as
a flip-flop switch (similar to a light switch) [33]. The hypothalamic sleep switch is quickly
turned “on” and “off,” with both positions being equally stable. It is hypothesized that the
circadian, homeostatic, and ultradian drives are responsible for flipping the hypothalamic
switch into the sleep and wake positions. The hypocretin tone, which also is influenced
by the circadian and homeostatic drives, helps to stabilize the hypothalamic switch in the
wake position and prevent intrusion of REM sleep into the waking state [23], [33]. When the
hypocretin tone is reduced, as in narcolepsy, this stability of the wake state is impaired
resulting in abnormal shifts from wake to REM states (eg, cataplexy, sleep paralysis).

PHARMACEUTICALS AND RECREATIONAL DRUGS
All drugs that cross the blood-brain barrier may affect sleep. Selective serotonin reuptake
inhibitors, tricyclic antidepressants, serotonin norepinephrine reuptake inhibitors, and
monoamine oxidase inhibitors suppress REM sleep; acute withdrawal from these
antidepressants is likely to produce a rebound increase in REM sleep. Barbiturates
increase slow-wave sleep and suppress REM. Benzodiazepines suppress slow-wave sleep
and do not affect REM. Psychostimulants, such as amphetamine and cocaine, increase
sleep latency, fragment sleep, and suppress REM sleep [4], [10], [12].

SLEEPING AND DREAMING
Many theories attempt to explain the biologic function of sleep, without a clear winner.
One such theory posits that sleep serves a restorative function for the brain and body.
Normal sleep is subjectively associated with feeling refreshed on awakening. REM sleep
is associated with increased CNS synthesis of proteins and is crucial for the CNS
development of infants and young humans and animals. Growth hormone secretion is
increased, while cortisol secretion is decreased during sleep. All these can be used to
support the restorative theory of sleep [34]. Another theory of sleep function proposes that
sleep has a central role in reinforcement and consolidation of memory. Sleep deprivation
experiments have highlighted the important role of REM sleep in memory function [34].

Another theory suggests that sleep is important for thermoregulatory function.
Experiments have shown that total sleep deprivation results in thermoregulatory
abnormalities, NREM sleep maintains thermoregulatory function, and REM sleep is
associated with impaired thermoregulatory responses (eg, shivering, sweating) [34].
Since the middle 1950s, when REM sleep was identified, sleep research has focused on
understanding the physiology of dreams. Most dreams (about 80%) occur during REM
sleep; the remainder occur during NREM sleep. REM sleep dreams are more complex,
have more emotional valence, can be bizarre, and are easier to recall. NREM sleep
dreams are more logical and realistic, but more difficult to recall possibly because
awakening from NREM sleep leaves a person feeling more confused and disoriented than
awakening from REM sleep. During REM sleep, neuronal signals originating from the
brainstem are transmitted to the cerebral hemispheres and stimulate the cortical
association areas to produce images that compose dreams [34].

SUMMARY
Sleep is a vital, highly organized process regulated by complex systems of neuronal
networks and neurotransmitters. Sleep plays an important role in the regulation of CNS
and body physiologic functions. Sleep architecture changes with age and is easily
susceptible to external and internal disruption. Reduction or disruption of sleep can affect
numerous functions varying from thermoregulation to learning and memory during the
waking state.
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Table 1 -- Physiologic changes with stages of sleep
Parameter
NREM

REM

Heart

Decreases

Irregular with increases and
decreases

Blood pressure

Unchanged and stable

Irregular with increases and
decreases

Respiration

Decreased rate

Irregular rate in phasic stage

Ventilation

Decreased tidal volume;
decreased hypoxic response

Decreased tidal volume in
phasic stage; decreased
hypoxic response

Upper airway muscle tone

Decreased

Further decreased

Temperature

Preserved thermoregulation

Increased temperature and
poikilothermia

Pupils

Constricted

Constricted in tonic stage;
dilated in phasic stage

Gastrointestinal

Failure of inhibition of acid
secretion; prolonged acid
clearance

Failure of inhibition of acid
secretion

Nocturnal penile
tumescence/clitoral
enlargement

Infrequent

Frequent

Data From Refs. [9], [35].

Fig. 1 Sleep and age. (Data from Williams RL, Karacan I, Hursch CJ.
Electroencephalography (EEG) of human sleep: clinical applications. New York: Wiley
& Sons; 1974.)

Fig. 2 Two-process model of sleep regulation. (Data from Edgar DM, Dement WC,
Fuller CA. Effect of SCN lesions on sleep in squirrel monkeys: evidence for opponent
processes in sleep-wake regulation. J Neurosci 1993;13:1065–79.)

Fig. 3 Sleep: neurochemistry. BF, basal forebrain cholinergic nuclei; CR, caudal raphe;
LDT/PPT, laterodorsal tegmental nuclei/pedunculopontine tegmental nuclei; PRF,
pontine reticular formation; TMN, tuberomammillary nucleus; VLPO, ventrolateral
preoptic nucleus. (From Mignot E, Taheri S, Nishino S. Sleeping with the hypothalamus:
emerging therapeutic targets for sleep disorders. Nat Neurosci 2002;5:1072; with
permission.)

